Logiscreen

TELA Bio Inc

$0.86
Market Cap 38.44M
ROE -1344.5%
Gross Margin 65.7%
Debt/Equity -10.7
Current Ratio 3.6
Revenue QoQ 2.9%
EPS QoQ -0.2%
F-Score 2

About

TELA Bio, Inc. is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials.

Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Devices

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-0.97
vs median 35.63
P/B
-7.40
vs median 2.25
ROE
-13.44
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics